ABBOTT LABORATORIES Stock-Based Compensation
ABBOTT LABORATORIES (ABT) reported Stock-Based Compensation of $317.00 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-04-29
- ABBOTT LABORATORIES share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $317.00M, a 9.69% increase year-over-year.
- ABBOTT LABORATORIES share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $113.00M, a 1.80% increase year-over-year.
- ABBOTT LABORATORIES share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $120.00M, a 2.56% increase year-over-year.
- ABBOTT LABORATORIES share-based payment arrangement, noncash expense for the quarter ending 2025-06-30 was $142.00M, a 0.71% increase year-over-year.
- ABBOTT LABORATORIES share-based payment arrangement, noncash expense for fiscal 2025 was $664.00M, a 1.34% decline from fiscal 2024.
- ABBOTT LABORATORIES share-based payment arrangement, noncash expense for fiscal 2024 was $673.00M, a 4.50% increase from fiscal 2023.
- ABBOTT LABORATORIES share-based payment arrangement, noncash expense for fiscal 2023 was $644.00M, a 5.99% decline from fiscal 2022.
- ABBOTT LABORATORIES share-based payment arrangement, noncash expense for fiscal 2022 was $685.00M, a 7.03% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $317.00M 10-Q · filed 2026-04-29 | $430.00M derived: sum of 2 quarters · filed 2026-04-29 | $550.00M derived: sum of 3 quarters · filed 2026-04-29 | $692.00M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-12-31 | $113.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $233.00M derived: sum of 2 quarters · filed 2026-02-20 | $375.00M derived: sum of 3 quarters · filed 2026-02-20 | $664.00M 10-K · filed 2026-02-20 | ||||
| 2025-09-30 | $120.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $262.00M derived: sum of 2 quarters · filed 2025-10-29 | $551.00M 10-Q · filed 2025-10-29 | $662.00M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-06-30 | $142.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $431.00M 10-Q · filed 2025-07-30 | $542.00M derived: sum of 3 quarters · filed 2026-04-29 | $659.00M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-03-31 | $289.00M 10-Q · filed 2026-04-29 | $400.00M derived: sum of 2 quarters · filed 2026-04-29 | $517.00M derived: sum of 3 quarters · filed 2026-04-29 | $658.00M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2024-12-31 | $111.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $228.00M derived: sum of 2 quarters · filed 2026-02-20 | $369.00M derived: sum of 3 quarters · filed 2026-02-20 | $673.00M 10-K · filed 2026-02-20 | ||||
| 2024-09-30 | $117.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $258.00M derived: sum of 2 quarters · filed 2025-10-29 | $562.00M 10-Q · filed 2025-10-29 | $676.00M derived: sum of 4 quarters · filed 2026-02-20 | ||||
| 2024-06-30 | $141.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $445.00M 10-Q · filed 2025-07-30 | $559.00M derived: sum of 3 quarters · filed 2026-02-20 | $676.00M derived: sum of 4 quarters · filed 2026-02-20 | ||||
| 2024-03-31 | $304.00M 10-Q · filed 2025-04-30 | $418.00M derived: sum of 2 quarters · filed 2026-02-20 | $535.00M derived: sum of 3 quarters · filed 2026-02-20 | $667.00M derived: sum of 4 quarters · filed 2026-02-20 | ||||
| 2023-12-31 | $114.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $231.00M derived: sum of 2 quarters · filed 2026-02-20 | $363.00M derived: sum of 3 quarters · filed 2026-02-20 | $644.00M 10-K · filed 2026-02-20 | ||||
| 2023-09-30 | $117.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $249.00M derived: sum of 2 quarters · filed 2024-10-31 | $530.00M 10-Q · filed 2024-10-31 | $645.00M derived: sum of 4 quarters · filed 2025-02-21 | ||||
| 2023-06-30 | $132.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $413.00M 10-Q · filed 2024-07-31 | $528.00M derived: sum of 3 quarters · filed 2025-02-21 | $651.00M derived: sum of 4 quarters · filed 2025-02-21 | ||||
| 2023-03-31 | $281.00M 10-Q · filed 2024-05-02 | $396.00M derived: sum of 2 quarters · filed 2025-02-21 | $519.00M derived: sum of 3 quarters · filed 2025-02-21 | $661.00M derived: sum of 4 quarters · filed 2025-02-21 | ||||
| 2022-12-31 | $115.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $238.00M derived: sum of 2 quarters · filed 2025-02-21 | $380.00M derived: sum of 3 quarters · filed 2025-02-21 | $685.00M 10-K · filed 2025-02-21 | ||||
| 2022-09-30 | $123.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $265.00M derived: sum of 2 quarters · filed 2023-11-01 | $570.00M 10-Q · filed 2023-11-01 | $676.00M derived: sum of 4 quarters · filed 2024-02-16 | ||||
| 2022-06-30 | $142.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $447.00M 10-Q · filed 2023-08-03 | $553.00M derived: sum of 3 quarters · filed 2024-02-16 | $667.00M derived: sum of 4 quarters · filed 2024-02-16 | ||||
| 2022-03-31 | $305.00M 10-Q · filed 2023-05-04 | $411.00M derived: sum of 2 quarters · filed 2024-02-16 | $525.00M derived: sum of 3 quarters · filed 2024-02-16 | $657.00M derived: sum of 4 quarters · filed 2024-02-16 | ||||
| 2021-12-31 | $106.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16 | $220.00M derived: sum of 2 quarters · filed 2024-02-16 | $352.00M derived: sum of 3 quarters · filed 2024-02-16 | $640.00M 10-K · filed 2024-02-16 | ||||
| 2021-09-30 | $114.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $246.00M derived: sum of 2 quarters · filed 2022-11-01 | $534.00M 10-Q · filed 2022-11-01 | $632.00M derived: sum of 4 quarters · filed 2023-02-17 | ||||
| 2021-06-30 | $132.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $420.00M 10-Q · filed 2022-08-02 | $518.00M derived: sum of 3 quarters · filed 2023-02-17 | $618.00M derived: sum of 4 quarters · filed 2023-02-17 | ||||
| 2021-03-31 | $288.00M 10-Q · filed 2022-05-03 | $386.00M derived: sum of 2 quarters · filed 2023-02-17 | $486.00M derived: sum of 3 quarters · filed 2023-02-17 | $601.00M derived: sum of 4 quarters · filed 2023-02-17 | ||||
| 2020-12-31 | $98.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-17 | $198.00M derived: sum of 2 quarters · filed 2023-02-17 | $313.00M derived: sum of 3 quarters · filed 2023-02-17 | $546.00M 10-K · filed 2023-02-17 | ||||
| 2020-09-30 | $100.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $215.00M derived: sum of 2 quarters · filed 2021-11-03 | $448.00M 10-Q · filed 2021-11-03 | $533.00M derived: sum of 4 quarters · filed 2022-02-18 | ||||
| 2020-06-30 | $115.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $348.00M 10-Q · filed 2021-08-04 | $433.00M derived: sum of 3 quarters · filed 2022-02-18 | $527.00M derived: sum of 4 quarters · filed 2022-02-18 | ||||
| 2020-03-31 | $233.00M 10-Q · filed 2021-05-05 | $318.00M derived: sum of 2 quarters · filed 2022-02-18 | $412.00M derived: sum of 3 quarters · filed 2022-02-18 | $526.00M derived: sum of 4 quarters · filed 2022-02-18 | ||||
| 2019-12-31 | $85.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | $179.00M derived: sum of 2 quarters · filed 2022-02-18 | $293.00M derived: sum of 3 quarters · filed 2022-02-18 | $519.00M 10-K · filed 2022-02-18 | ||||
| 2019-09-30 | $94.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $208.00M derived: sum of 2 quarters · filed 2020-11-04 | $434.00M 10-Q · filed 2020-11-04 | $515.00M derived: sum of 4 quarters · filed 2021-02-19 | ||||
| 2019-06-30 | $114.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $340.00M 10-Q · filed 2020-07-29 | $421.00M derived: sum of 3 quarters · filed 2021-02-19 | $504.00M derived: sum of 4 quarters · filed 2021-02-19 | ||||
| 2019-03-31 | $226.00M 10-Q · filed 2020-04-29 | $307.00M derived: sum of 2 quarters · filed 2021-02-19 | $390.00M derived: sum of 3 quarters · filed 2021-02-19 | $491.00M derived: sum of 4 quarters · filed 2021-02-19 | ||||
| 2018-12-31 | $81.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $164.00M derived: sum of 2 quarters · filed 2021-02-19 | $265.00M derived: sum of 3 quarters · filed 2021-02-19 | $477.00M 10-K · filed 2021-02-19 | ||||
| 2018-09-30 | $83.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $184.00M derived: sum of 2 quarters · filed 2019-10-31 | $396.00M 10-Q · filed 2019-10-31 | $464.00M derived: sum of 4 quarters · filed 2020-02-21 | ||||
| 2018-06-30 | $101.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $313.00M 10-Q · filed 2019-07-31 | $381.00M derived: sum of 3 quarters · filed 2020-02-21 | $456.00M derived: sum of 4 quarters · filed 2020-02-21 | ||||
| 2018-03-31 | $212.00M 10-Q · filed 2019-05-01 | $280.00M derived: sum of 2 quarters · filed 2020-02-21 | $355.00M derived: sum of 3 quarters · filed 2020-02-21 | $447.00M derived: sum of 4 quarters · filed 2020-02-21 | ||||
| 2017-12-31 | $68.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $143.00M derived: sum of 2 quarters · filed 2020-02-21 | $235.00M derived: sum of 3 quarters · filed 2020-02-21 | $406.00M 10-K · filed 2020-02-21 | ||||
| 2017-09-30 | $75.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $167.00M derived: sum of 2 quarters · filed 2018-10-31 | $338.00M 10-Q · filed 2018-10-31 | $385.00M derived: sum of 4 quarters · filed 2019-02-22 | ||||
| 2017-06-30 | $92.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $263.00M 10-Q · filed 2018-08-01 | $310.00M derived: sum of 3 quarters · filed 2019-02-22 | $359.00M derived: sum of 4 quarters · filed 2019-02-22 | ||||
| 2017-03-31 | $171.00M 10-Q · filed 2018-05-02 | $218.00M derived: sum of 2 quarters · filed 2019-02-22 | $267.00M derived: sum of 3 quarters · filed 2019-02-22 | $329.00M derived: sum of 4 quarters · filed 2019-02-22 | ||||
| 2016-12-31 | $47.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $96.00M derived: sum of 2 quarters · filed 2019-02-22 | $158.00M derived: sum of 3 quarters · filed 2019-02-22 | $310.00M 10-K · filed 2019-02-22 | ||||
| 2016-09-30 | $49.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $111.00M derived: sum of 2 quarters · filed 2017-11-02 | $263.00M 10-Q · filed 2017-11-02 | $306.00M derived: sum of 4 quarters · filed 2018-02-16 | ||||
| 2016-06-30 | $62.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $214.00M 10-Q · filed 2017-08-02 | $257.00M derived: sum of 3 quarters · filed 2018-02-16 | $301.00M derived: sum of 4 quarters · filed 2018-02-16 | ||||
| 2016-03-31 | $152.00M 10-Q · filed 2017-05-03 | $195.00M derived: sum of 2 quarters · filed 2018-02-16 | $239.00M derived: sum of 3 quarters · filed 2018-02-16 | $296.00M derived: sum of 4 quarters · filed 2018-02-16 | ||||
| 2015-12-31 | $43.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $87.00M derived: sum of 2 quarters · filed 2018-02-16 | $144.00M derived: sum of 3 quarters · filed 2018-02-16 | $292.00M 10-K · filed 2018-02-16 | ||||
| 2015-09-30 | $44.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $101.00M derived: sum of 2 quarters · filed 2016-11-03 | $249.00M 10-Q · filed 2016-11-03 | $287.00M derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2015-06-30 | $57.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $205.00M 10-Q · filed 2016-08-03 | $243.00M derived: sum of 3 quarters · filed 2017-02-17 | $283.00M derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2015-03-31 | $148.00M 10-Q · filed 2016-05-04 | $186.00M derived: sum of 2 quarters · filed 2017-02-17 | $226.00M derived: sum of 3 quarters · filed 2017-02-17 | $275.00M derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2014-12-31 | $38.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $78.00M derived: sum of 2 quarters · filed 2017-02-17 | $127.00M derived: sum of 3 quarters · filed 2017-02-17 | $246.00M 10-K · filed 2017-02-17 | ||||
| 2014-09-30 | $40.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $89.00M derived: sum of 2 quarters · filed 2015-11-05 | $208.00M 10-Q · filed 2015-11-05 | $248.00M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-06-30 | $49.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | $168.00M 10-Q · filed 2015-08-04 | $208.00M derived: sum of 3 quarters · filed 2016-02-19 | $253.00M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-03-31 | $119.00M 10-Q · filed 2015-05-06 | $159.00M derived: sum of 2 quarters · filed 2016-02-19 | $204.00M derived: sum of 3 quarters · filed 2016-02-19 | $255.00M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2013-12-31 | $40.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $85.00M derived: sum of 2 quarters · filed 2016-02-19 | $136.00M derived: sum of 3 quarters · filed 2016-02-19 | $262.00M 10-K · filed 2016-02-19 | ||||
| 2013-09-30 | $45.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $96.00M derived: sum of 2 quarters · filed 2014-11-06 | $222.00M 10-Q · filed 2014-11-06 | $222.05M 10-Q · filed 2013-11-07 | $296.26M derived: sum of 4 quarters · filed 2015-02-27 | |||
| 2013-06-30 | $51.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $177.00M 10-Q · filed 2014-08-05 | $177.29M 10-Q · filed 2013-08-06 | $251.26M derived: sum of 3 quarters · filed 2015-02-27 | $326.87M derived: sum of 4 quarters · filed 2015-02-27 | |||
| 2013-03-31 | $126.00M 10-Q · filed 2014-05-07 | $125.75M 10-Q · filed 2013-05-08 | $200.26M derived: sum of 2 quarters · filed 2015-02-27 | $275.87M derived: sum of 3 quarters · filed 2015-02-27 | $361.66M derived: sum of 4 quarters · filed 2015-02-27 | |||
| 2012-12-31 | $74.27M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $149.87M derived: sum of 2 quarters · filed 2015-02-27 | $235.66M derived: sum of 3 quarters · filed 2015-02-27 | $433.00M 10-K · filed 2015-02-27 | $433.11M 10-K · filed 2013-02-15 | |||
| 2012-09-30 | $75.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $161.39M derived: sum of 2 quarters · filed 2013-11-07 | $358.74M 10-Q · filed 2013-11-07 | $421.63M derived: sum of 4 quarters · filed 2014-02-21 | ||||
| 2012-06-30 | $85.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $283.13M 10-Q · filed 2013-08-06 | $346.02M derived: sum of 3 quarters · filed 2014-02-21 | $413.86M derived: sum of 4 quarters · filed 2014-02-21 | ||||
| 2012-03-31 | $197.34M 10-Q · filed 2013-05-08 | $260.24M derived: sum of 2 quarters · filed 2014-02-21 | $328.08M derived: sum of 3 quarters · filed 2014-02-21 | $404.53M derived: sum of 4 quarters · filed 2014-02-21 | ||||
| 2011-12-31 | $62.90M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21 | $130.74M derived: sum of 2 quarters · filed 2014-02-21 | $207.19M derived: sum of 3 quarters · filed 2014-02-21 | $383.00M 10-K · filed 2014-02-21 | $382.60M 10-K · filed 2012-02-21 | |||
| 2011-09-30 | $67.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $144.29M derived: sum of 2 quarters · filed 2012-11-07 | $320.10M 10-Q · filed 2012-11-07 | $377.05M derived: sum of 4 quarters · filed 2013-02-15 | ||||
| 2011-06-30 | $76.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $252.26M 10-Q · filed 2012-08-07 | $309.21M derived: sum of 3 quarters · filed 2013-02-15 | $381.36M derived: sum of 4 quarters · filed 2013-02-15 | ||||
| 2011-03-31 | $175.81M 10-Q · filed 2012-05-08 | $232.75M derived: sum of 2 quarters · filed 2013-02-15 | $304.90M derived: sum of 3 quarters · filed 2013-02-15 | $389.13M derived: sum of 4 quarters · filed 2013-02-15 | ||||
| 2010-12-31 | $56.95M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-15 | $129.09M derived: sum of 2 quarters · filed 2013-02-15 | $213.32M derived: sum of 3 quarters · filed 2013-02-15 | $387.18M 10-K · filed 2013-02-15 | ||||
| 2010-09-30 | $72.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $156.37M derived: sum of 2 quarters · filed 2011-11-04 | $330.24M 10-Q · filed 2011-11-04 | $389.10M derived: sum of 4 quarters · filed 2012-02-21 | ||||
| 2010-06-30 | $84.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-04 | $258.09M 10-Q · filed 2011-08-04 | $316.95M derived: sum of 3 quarters · filed 2012-02-21 | $379.54M derived: sum of 4 quarters · filed 2012-02-21 | ||||
| 2010-03-31 | $173.87M 10-Q · filed 2011-05-06 | $232.72M derived: sum of 2 quarters · filed 2012-02-21 | $295.31M derived: sum of 3 quarters · filed 2012-02-21 | $353.28M derived: sum of 4 quarters · filed 2012-02-21 | ||||
| 2009-12-31 | $58.86M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-21 | $121.45M derived: sum of 2 quarters · filed 2012-02-21 | $179.41M derived: sum of 3 quarters · filed 2012-02-21 | $366.36M 10-K · filed 2012-02-21 | ||||
| 2009-09-30 | $62.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-05 | $120.55M derived: sum of 2 quarters · filed 2010-11-05 | $307.50M 10-Q · filed 2010-11-05 | $368.32M derived: sum of 4 quarters · filed 2011-02-18 | ||||
| 2009-06-30 | $57.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-05 | $244.91M 10-Q · filed 2010-08-05 | $305.74M derived: sum of 3 quarters · filed 2011-02-18 | $372.13M derived: sum of 4 quarters · filed 2011-02-18 | ||||
| 2009-03-31 | $186.95M 10-Q · filed 2010-05-04 | $247.77M derived: sum of 2 quarters · filed 2011-02-18 | $314.17M derived: sum of 3 quarters · filed 2011-02-18 | |||||
| 2008-12-31 | $60.82M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-18 | $127.22M derived: sum of 2 quarters · filed 2011-02-18 | $347.01M 10-K · filed 2011-02-18 | |||||
| 2008-09-30 | $66.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-06 | $286.19M 10-Q · filed 2009-11-06 | ||||||
| 2008-06-30 | $219.79M 10-Q · filed 2009-08-07 | |||||||
| 2007-12-31 | $429.68M 10-K · filed 2010-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |